Biocon Ltd

NSE :BIOCON   BSE :532523  Sector : Pharmaceuticals
Buy, Sell or Hold BIOCON? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

24 Dec
344.50
(4.54%)
23 Dec
329.55
(-1.91%)
20 Dec
335.95
(-4.11%)
19 Dec
350.35
(0.66%)
18 Dec
348.05
(-0.83%)
17 Dec
350.95
(-0.78%)
16 Dec
353.70
(0.26%)
13 Dec
352.80
(-1.09%)
12 Dec
356.70
(-3.03%)
11 Dec
367.85
(-0.37%)
10 Dec
369.20
(-0.11%)
09 Dec
369.60
(-2.75%)
06 Dec
380.05
(1.28%)
05 Dec
375.25
(-1.17%)
04 Dec
379.70
(1.56%)
03 Dec
373.85
(-0.40%)
02 Dec
375.35
(2.79%)
29 Nov
365.15
(0.33%)
28 Nov
363.95
(1.48%)
27 Nov
358.65
(1.70%)
26 Nov
352.65
(4.85%)


Technical Analysis

Short Term Investors

Bearish

Medium Term Investors

Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bullish

341.72


10 DMA
Bearish

348.99


20 DMA
Bearish

360.01


50 DMA
Bullish

342.21


100 DMA
Bearish

350.32


200 DMA
Bullish

330.03



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Dec 24, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 366.44 357.07 348.8 - -
R2 357.07 351.09 347.37 357.84 -
R1 350.79 347.4 345.93 352.33 353.93
P 341.42 341.42 341.42 342.19 342.99
S1 335.14 335.44 343.07 336.68 338.28
S2 325.77 331.75 341.63 326.54 -
S3 319.49 325.77 340.2 - -

Key Metrics

EPS

0.35

P/E

0

P/B

3.8

Dividend Yield

0.15%

Market Cap

41,361 Cr.

Face Value

5

Book Value

90.7

ROE

6.89%

EBITDA Growth

742.9 Cr.

Debt/Equity

0.91

Shareholding Pattern

  60.64% Total Promoter Holding
7.97% Mutual Fund Holdings
5.93% FIIs
18.75% Non Institution
6.23% Insurance Companies
0.25% Custodians
0.23% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Biocon Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME3620.2 4540.4 3965.7 4599.4 3648.9
PROFIT143.74 640.97 140.55 635.63 -23.16
EPS1.05 5.52 1.13 5.51 -0.13

Biocon Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME588.3 611.3 571.5 552.5 598.9
PROFIT38.62 24 14 0.9 3.2
EPS0.29 0.2 0.12 0.01 0.03

Profit & Loss (Figures in Rs. Crores)


Biocon Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 3329.6 3757.2 4133.5 4392.6 6064 6730.2 7700.3 8653.3 11704.2 16477.9
PROFIT 410.01 345.56 609.16 328.65 725.03 690.28 729.97 747.32 692.56 978.2
EPS 4.23 5.08 5.73 3.78 8.36 7.26 7.05 6.43 5.36 10.81

Biocon Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 2429.9 2617.4 2733.2 2545.7 2276.8 2385.8 2141.9 2031.2 5123.9 2433.9
PROFIT 378.19 302.77 516.38 213.46 326.06 304.63 277.5 83.18 -13.33 105.89
EPS 2.99 3.07 4.33 1.99 4.11 3.67 2.34 0.72 23.72 0.99

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 600.3600.3600.3600600300300100100100
Reserves Total 19,183.417,266.67,832.27,026.96,105.85,7984,880.84,737.73,933.83,170.6
Total Shareholders Funds19,783.717,866.98,432.57,626.96,705.86,0985,180.84,837.74,033.83,270.6
Minority Interest5,491.14,621.91,037.5880.7677.3608.9467.7376.1265.8172.2
Secured Loans 11,957.413,7952,621.72,295.22,041.82,214.22,166.42,233.82,237.4830.8
Unsecured Loans 4,319.34,223.82,524.92,185.9673.5207.997.668.7240.3286.4
Total Debt16,276.718,018.85,146.64,481.12,715.32,422.12,2642,302.52,477.71,117.2
Other Liabilities1,620.85,161.92,823.72,696.61,717.6906.3410.1393.9420.4566.6
Total Liabilities43,172.345,669.517,440.315,685.311,81610,035.38,322.67,910.27,197.75,126.6
APPLICATION OF FUNDS :
Gross Block 37,930.135,321.411,23310,220.99,147.47,0955,873.85,431.43,403.63,042.3
Less: Accumulated Depreciation7,286.55,853.74,6643,8573,176.32,6242,174.31,805.51,655.31,412.4
Net Block30,643.629,467.76,5696,363.95,971.14,4713,699.53,625.91,748.31,629.9
Capital Work in Progress7,993.37,3174,110.42,800.22,1961,898.91,302.8839.22,239.51,676.6
Investments 999.72,068.81,587.91,951.9966.11,011.8675.21,253901.5230.3
Inventories 4,943.94,243.72,298.21,866.61,435.91,031.6722.5635.3542.4452.7
Sundry Debtors 6,230.63,573.22,058.21,503.31,223.71,291.81,063.9883.2714.5770.5
Cash and Bank Balance2,258.72,400.11,747.52,015.4998.61,057.21,322.81,044.31,538.6937.5
Loans and Advances 1,430.4790.51,060.71,006.4809.2678.6428419.9300.7171.6
Total Current Assets14,863.611,007.57,164.66,391.74,467.44,059.23,537.22,982.73,096.22,332.3
Current Liabilities 12,050.55,617.92,609.12,542.92,367.11,952.81,531.51,340.81,126.51,048.9
Provisions 456.4373.6292.3261.8230.9204.3135.6143.2133.9158.2
Total Current Liabilities & Provisions12,506.95,991.52,901.42,804.72,5982,157.11,667.11,4841,260.41,207.1
Net Current Assets2,356.75,0164,263.23,5871,869.41,902.11,870.11,498.71,835.81,125.2
Deferred Tax Assets317.33011,150.1307.7368558.1295.9289.1140.112.3
Deferred Tax Liability391.5381.8909.132.329.8233.4102.591.668.654
Net Deferred Tax-74.2-80.8241275.4338.2324.7193.4197.571.5-41.7
Other Assets1,253.21,880.8668.8706.9475.2426.8581.6495.9401.1506.3
Total Assets43,172.345,669.517,440.315,685.311,81610,035.38,322.67,910.27,197.75,126.6
Contingent Liabilities1,140.6947.8844.47001,4191,601.1588.9594590.5364.7
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 600.3600.3600.3600600300300100100100
Reserves Total 10,31210,315.77,492.67,307.16,937.36,815.46,438.66,441.15,896.62,484.4
Total Shareholders Funds10,912.310,9168,092.97,907.17,537.37,115.46,738.66,541.15,996.62,584.4
Secured Loans 2,040.81,297.775.90069.3130.2129.6132.80
Unsecured Loans 23.513.142.12.83.9236.781.5
Total Debt2,042.81,301.276.93.1471.4133133.5369.581.5
Other Liabilities123.2116109.2115.242.2130.389.590.2101.5136.4
Total Liabilities13,078.312,333.28,2798,025.47,583.57,317.16,961.16,764.86,467.62,802.3
APPLICATION OF FUNDS :
Gross Block 2,586.82,479.72,269.72,098.11,993.32,581.32,236.72,128.91,934.41,832.1
Less : Accumulated Depreciation 1,628.41,518.31,399.51,3001,200.11,480.21,334.11,190.91,040.6917.8
Net Block 958.4961.4870.2798.1793.21,101.1902.6938893.8914.3
Capital Work in Progress559.6343.5284.9179.2151.9254.5318.5240.8172.357.6
Investments 9,318.59,270.75,2805,412.74,952.84,093.14,1993,888.23,852.8164.7
Inventories 664.7560.1541.5430.9534.7801.9561.7539.6504.6406.3
Sundry Debtors 1,048.1658700.6605.4573.2901.8739.9798.2503.8555.1
Cash and Bank Balance585.7720.3689.3601.2375.3356196.9382.9643621.2
Loans and Advances 398.6306.7208.6192.5461.7338.3105.4133.1121.469
Total Current Assets2,697.12,245.12,1401,8301,944.92,3981,603.91,853.81,772.81,651.6
Current Liabilities 556.8571.3474.3435.6618.1788.2660.2594.4528.2347.1
Provisions 133.1125.4115.7112.7109.2135.1105.6109.7101.4146.8
Total Current Liabilities & Provisions689.9696.7590548.3727.3923.3765.8704.1629.6493.9
Net Current Assets2,007.21,548.41,5501,281.71,217.61,474.7838.11,149.71,143.21,157.7
Deferred Tax Assets3744.9159.6195.4226.3258158.8162.307.2
Deferred Tax Liability29.622.139.64946.856.156.656.90.944
Net Deferred Tax7.422.8120146.4179.5201.9102.2105.4-0.9-36.8
Other Assets227.2186.4173.9207.3288.5191.8600.7442.7406.4544.8
Total Assets13,078.312,333.28,2798,025.47,583.57,317.16,961.16,764.86,467.62,802.3
Contingent Liabilities911.6681.7525.71,574.92,225.82,160.61,677.71,668.51,532.91,082.7

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...1,297.8
Depreciation1,568.8
Interest (Net)813.1
P/L on Sales of Assets1.2
P/L on Sales of Invest-173.9
Prov. and W/O (Net)-17.1
P/L in Forex-105.4
Total Adjustments (PBT and Ext...2,583.6
Operating Profit before Workin...3,881.4
Trade and 0ther Receivables-2,417.4
Inventories-886.4
Trade Payables2,936.5
Total Adjustments (OP before W...-635.2
Cash Generated from/(used in) ...3,246.2
Direct Taxes Paid-292.3
Total Adjustments(Cash Generat...-292.3
Cash Flow before Extraordinary...2,953.9
Net Cash from Operating Activi...2,953.9
Purchased of Fixed Assets-1,931.6
Sale of Fixed Assets23.3
Purchase of Investments-3,770.8
Sale of Investments3,968.2
Interest Received144.6
Net Cash used in Investing Act...-1,001.6
Proceeds from Issue of shares ...30.7
Proceed from Issue of Debentur...800
Proceed from 0ther Long Term B...571.8
Proceed from Short Tem Borrowi...124.8
Of the Long Tem Borrowings-2,767.8
Of Financial Liabilities-41.8
Dividend Paid-203
Interest Paid-847.4
Net Cash used in Financing Act...-2,332.7
Net Profit before Tax and Extr...119.3
Depreciation121.1
Interest (Net)133.1
Dividend Received27.4
P/L on Sales of Assets1.1
P/L on Sales of Invest-23.2
Prov. and W/O (Net)-37
P/L in Forex4
Total Adjustments (PBT and Ext...143.3
Operating Profit before Workin...262.6
Trade and 0ther Receivables-355.6
Inventories-104.6
Trade Payables-0.3
Total Adjustments (OP before W...-358.3
Cash Generated from/(used in) ...-95.7
Direct Taxes Paid-27.5
Total Adjustments(Cash Generat...-27.5
Cash Flow before Extraordinary...-123.2
Net Cash from Operating Activi...-123.2
Purchased of Fixed Assets-307
Sale of Fixed Assets1.3
Purchase of Investments-682.3
Sale of Investments764.6
Interest Received41.7
Invest.In Subsidiaires-500
Loans to Subsidiaires-136.7
Cancellation of Investment in ...23.4
Net Cash used in Investing Act...-294.7
Proceeds from Issue of shares ...30.7
Proceed from 0ther Long Term B...500
Of Financial Liabilities-1.3
Dividend Paid-180.1
Interest Paid-5.7
Net Cash used in Financing Act...343.6

Company Details

Registered Office
Address20th KM Hosur Road Hebbagodi,
Electronic City P O
CityBangalore
StateKarnataka
Pin Code560100
Tel. No.91-80-28082808
Fax. No.91-80-28523423
Emailco.secretary@biocon.com
Internethttp://www.biocon.com
Registrars
Address20th KM Hosur Road Hebbagodi
CityBangalore
StateKarnataka
Pin Code560100
Tel. No.91-80-28082808
Fax. No.91-80-28523423
Emailco.secretary@biocon.com
Internethttp://www.biocon.com
Management
Name Designation
Kiran Mazumdar ShawChairperson
Ravi MazumdarNon Executive Director
M DamodaranLead Independent Director
Bobby ParikhIndependent Director
Mayank VermaCompany Sec. & Compli. Officer
SIDDHARTH MITTALManaging Director & CEO
Eric Vivek MazumdarNon Executive Director
Naina Lal KidwaiIndependent Director
Atul DhawanIndependent Director
Rekha Mehrotra MenonIndependent Director
NICHOLAS ROBERT HAGGARIndependent Director